Irska - angleščina - HPRA (Health Products Regulatory Authority)

elpen pharmaceutical co. inc. - salmeterol; fluticasone propionate - inhalation powder, pre-dispensed - 50/500 microgram(s) - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; salmeterol and fluticasone

Irska - angleščina - HPRA (Health Products Regulatory Authority)

rowex ltd - simvastatin - film-coated tablet - 20 milligram(s) - hmg coa reductase inhibitors; simvastatin

Irska - angleščina - HPRA (Health Products Regulatory Authority)

rowex ltd - simvastatin - film-coated tablet - 10 milligram(s) - hmg coa reductase inhibitors; simvastatin

Irska - angleščina - HPRA (Health Products Regulatory Authority)

rowex ltd - simvastatin - film-coated tablet - 40 milligram(s) - hmg coa reductase inhibitors; simvastatin

Kanada - angleščina - Health Canada

marcan pharmaceuticals inc - quetiapine (quetiapine fumarate) - tablet (immediate release) - 25mg - quetiapine (quetiapine fumarate) 25mg - atypical antipsychotics

Kanada - angleščina - Health Canada

marcan pharmaceuticals inc - quetiapine (quetiapine fumarate) - tablet (immediate release) - 100mg - quetiapine (quetiapine fumarate) 100mg - atypical antipsychotics

Kanada - angleščina - Health Canada

marcan pharmaceuticals inc - quetiapine (quetiapine fumarate) - tablet (immediate release) - 200mg - quetiapine (quetiapine fumarate) 200mg - atypical antipsychotics

Kanada - angleščina - Health Canada

marcan pharmaceuticals inc - quetiapine (quetiapine fumarate) - tablet (immediate release) - 300mg - quetiapine (quetiapine fumarate) 300mg - atypical antipsychotics

Združene države Amerike - angleščina - NLM (National Library of Medicine)

versapharm incorporated - rifampin (unii: vjt6j7r4tr) (rifampin - unii:vjt6j7r4tr), isoniazid (unii: v83o1voz8l) (isoniazid - unii:v83o1voz8l) - rifampin 300 mg - for pulmonary tuberculosis in which organisms are susceptible, and when the patient has been titrated on theindividual components and it has therefore been established that this fixed dosage is therapeutically effective. this fixed-dosage combination drug is not recommended for initial therapy of tuberculosis or for preventive therapy. in the treatment of tuberculosis, small numbers of resistant cells, present within large populations of susceptiblecells, can rapidly become the predominating type. since rapid emergence of resistance can occur, culture andsusceptibility tests should be performed in the event of persistent positive cultures. this drug is not indicated for the treatment of meningococcal infections or asymptomatic carriers of n. meningitides to eliminate meningococci from the nasopharynx. previous isoniazid-associated hepatic injury; severe adverse reactions to isoniazid, such as drug fever, chills, andarthritis; acute liver disease of any etiology. a history of previous hypersensitivity reactio

Armenija - angleščina - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

bayer healthcare manufacturing s.r.l. - methylprednisolone (methylprednisolone aceponate) - cream for external use - 1mg/g